Praiss, A. M., Huang, Y., St. Clair, C. M., Melamed, A., Khoury-Collado, F., Hou, J. Y., Gockley, A., Hillyer, G. C., Hershman, D. L., & Wright, J. D. (2022). Long-term outcomes of vaginal hysterectomy for endometrial cancer. Gynecologic Oncology, 164(1), 105–112. https://doi.org/10.1016/j.ygyno.2021.10.082

Heaney, M. L. (2022). Can the treatment of myeloproliferative neoplasms be both good and bad for you? The Lancet Haematology, 9(1), e3–e4. https://doi.org/10.1016/s2352-3026(21)00371-9

Rush, R. E., Dannemiller, K. C., Cochran, S. J., Haines, S. R., Acosta, L., Divjan, A., Rundle, A. G., Miller, R. L., Perzanowski, M. S., Croston, T. L., & Green, B. J. (2021). Vishniacozyma victoriae (syn. Cryptococcus victoriae) in the homes of asthmatic and non-asthmatic children in New York City. Journal of Exposure Science & Environmental Epidemiology, 32(1), 48–59. https://doi.org/10.1038/s41370-021-00342-4

Tan, A. R., Chan, N., Kiesel, B. F., Stein, M. N., Moss, R. A., Malhotra, J., Aisner, J., Shah, M., Gounder, M., Lin, H., Kane, M. P., Lin, Y., Ji, J., Chen, A., Beumer, J. H., & Mehnert, J. M. (2021). A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies. Cancer Chemotherapy and Pharmacology, 89(1), 49–58. https://doi.org/10.1007/s00280-021-04350-x

Akpan, I. J., & Pavord, S. (2022). Gynecologic Conditions and Anemia: What Can We Do About Iron Deficiency Anemia in Women? The Hematologist, 19(3). https://doi.org/10.1182/hem.v19.3.2022311

Jacobson, C. A., Chavez, J. C., Sehgal, A. R., William, B. M., Munoz, J., Salles, G., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Yakoub-Agha, I., Oluwole, O. O., Fung, H. C. H., Rosenblatt, J., Rossi, J. M., Goyal, L., Plaks, V., … Neelapu, S. S. (2022). Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. The Lancet Oncology, 23(1), 91–103. https://doi.org/10.1016/s1470-2045(21)00591-x

Leeman-Neill, R. J., Soderquist, C. R., Montanari, F., Raciti, P., Park, D., Radeski, D., Mansukhani, M. M., Murty, V. V., Hsiao, S., Alobeid, B., & Bhagat, G. (2020). Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. Haematologica, 107(1), 201–210. https://doi.org/10.3324/haematol.2020.267294

Macedo, R., Pasin, C., Ganetsky, A., Harle, D., Wang, X. K., Belay, K., Richman, L. P., Huffman, A. P., Vonderheide, R. H., Yates, A. J., Porter, D. L., Wang, Y., Zhang, Y., & Reshef, R. (2022). Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature. Transplantation and Cellular Therapy, 28(1), 18.e1-18.e10. https://doi.org/10.1016/j.jtct.2021.09.017

Zhang, X., Wolff, M. S., Shen, J., Parada, H., Santella, R. M., Neugut, A. I., Chen, J., & Teitelbaum, S. L. (2022). Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project. Cancer Epidemiology, Biomarkers & Prevention, 31(1), 117–123. https://doi.org/10.1158/1055-9965.epi-21-0830

Pumpalova, Y., Rogers, A. M., Tan, S. X., Herbst, C., Ruff, P., Neugut, A. I., & Hur, C. (2021). Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals. JCO Global Oncology, 7, 1730–1741. https://doi.org/10.1200/go.21.00279

Delahanty, L. M., Wadden, T. A., Goodwin, P. J., Alfano, C. M., Thomson, C. A., Irwin, M. L., Neuhouser, M. L., Crane, T. E., Frank, E., Spears, P. A., Gillis, B. P., Hershman, D. L., Paskett, E. D., Hopkins, J., Bernstein, V., Stearns, V., White, J., Hudis, C., Winer, E. P., … Ligibel, J. A. (2021). The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity, 30(1), 28–38. Portico. https://doi.org/10.1002/oby.23287

Son, J., Ding, H., Farb, T. B., Efanov, A. M., Sun, J., Gore, J. L., Syed, S. K., Lei, Z., Wang, Q., Accili, D., & Califano, A. (2021). BACH2 inhibition reverses β cell failure in type 2 diabetes models. Journal of Clinical Investigation, 131(24). https://doi.org/10.1172/jci153876

Gil, V., Miranda, S., Riisnaes, R., Gurel, B., D’Ambrosio, M., Vasciaveo, A., Crespo, M., Ferreira, A., Brina, D., Troiani, M., Sharp, A., Sheehan, B., Christova, R., Seed, G., Figueiredo, I., Lambros, M., Dolling, D., Rekowski, J., Alajati, A., … de Bono, J. (2021). HER3 Is an Actionable Target in Advanced Prostate Cancer. Cancer Research, 81(24), 6207–6218. https://doi.org/10.1158/0008-5472.can-21-3360

Unger, J. M., Beauchemin, M., & Hershman, D. L. (2021). Adolescent and young adult enrollment to a National Cancer Institute–sponsored National Clinical Trials Network Research Group over 25 years. Cancer, 127(24), 4574–4584. Portico. https://doi.org/10.1002/cncr.33855

Chakraborty, R. (2021). Anticancer Drug Approvals in the Past Decade—Quality vs Quantity. JAMA Network Open, 4(12), e2139178. https://doi.org/10.1001/jamanetworkopen.2021.39178

Henry, N. L., Unger, J. M., Till, C., Crew, K. D., Fisch, M. J., & Hershman, D. L. (2021). Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms. JNCI Cancer Spectrum, 5(6). https://doi.org/10.1093/jncics/pkab087

Khosravi-Maharlooei, M., Madley, R., Borsotti, C., Ferreira, L. M. R., Sharp, R. C., Brehm, M. A., Greiner, D. L., Parent, A. V., Anderson, M. S., Sykes, M., & Creusot, R. J. (2022). Modeling human T1D-associated autoimmune processes. Molecular Metabolism, 56, 101417. https://doi.org/10.1016/j.molmet.2021.101417

Fu, J., & Sykes, M. (2022). Emerging Concepts of Tissue-resident Memory T Cells in Transplantation. Transplantation, 106(6), 1132–1142. https://doi.org/10.1097/tp.0000000000004000

Bhattacharya, P. T., Fox, A. N., Marboe, C. C., Lagana, S. M., Remotti, H. E., D’Armiento, J. M., Goldklang, M. P., Eisenberger, A. B., Griffin, J. M., & Maurer, M. S. (2021). Can lightning strike twice? Wild-type transthyretin cardiac amyloidosis associated with rare liver disease. Oxford Medical Case Reports, 2021(11–12). https://doi.org/10.1093/omcr/omab113

Pasin, C., Moy, R. H., Reshef, R., & Yates, A. J. (2021). Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-82562-0

Goodwin, P. J., Dowling, R. J. O., Ennis, M., Chen, B. E., Parulekar, W. R., Shepherd, L. E., Burnell, M. J., Vander Meer, R., Molckovsky, A., Gurjal, A., Gelmon, K. A., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Whelan, T. J., Hobday, T. J., Rastogi, P., Rabaglio-Poretti, M., Lemieux, J., … Stambolic, V. (2021). Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial. Npj Breast Cancer, 7(1). https://doi.org/10.1038/s41523-021-00275-z

Oiwa, K., Hosono, N., Nishi, R., Scotto, L., O’Connor, O. A., & Yamauchi, T. (2021). Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08607-9

Callan, M. B., Thawley, V. J., Marryott, K. A., Shabro, A., Fernando, S., Kahn, S., Hudson, K. E., & Hod, E. A. (2021). Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs. Transfusion, 61(12), 3309–3319. Portico. https://doi.org/10.1111/trf.16690

Vogl, U. M., Beer, T. M., Davis, I. D., Shore, N. D., Sweeney, C. J., Ost, P., Attard, G., Bossi, A., de Bono, J., Drake, C. G., Efstathiou, E., Fanti, S., Fizazi, K., Halabi, S., James, N., Mottet, N., Padhani, A. R., Roach, M., Rubin, M., … Gillessen, S. (2022). Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. European Journal of Cancer, 160, 24–60. https://doi.org/10.1016/j.ejca.2021.09.036

Altoe, M. L., Kalinsky, K., Marone, A., Kim, H. K., Guo, H., Hibshoosh, H., Tejada, M., Crew, K. D., Accordino, M. K., Trivedi, M. S., Hershman, D. L., & Hielscher, A. H. (2021). Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography. Breast Cancer Research, 23(1). https://doi.org/10.1186/s13058-021-01396-w

Giddings, E. L., Champagne, D. P., Wu, M.-H., Laffin, J. M., Thornton, T. M., Valenca-Pereira, F., Culp-Hill, R., Fortner, K. A., Romero, N., East, J., Cao, P., Arias-Pulido, H., Sidhu, K. S., Silverstrim, B., Kam, Y., Kelley, S., Pereira, M., Bates, S. E., Bunn, J. Y., … Rincon, M. (2021). Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-23071-6

Kojadinovic, A., & Mundi, P. S. (2021). Primary Adrenal Insufficiency and Acute Cardiomyopathy in a Patient With Colorectal Cancer Treated With Dual Immune Checkpoint Inhibitors. Clinical Colorectal Cancer, 20(4), e249–e252. https://doi.org/10.1016/j.clcc.2021.07.002

Autio, K. A., Antonarakis, E. S., Mayer, T. M., Shevrin, D. H., Stein, M. N., Vaishampayan, U. N., Morris, M. J., Slovin, S. F., Heath, E. I., Tagawa, S. T., Rathkopf, D. E., Milowsky, M. I., Harrison, M. R., Beer, T. M., Balar, A. V., Armstrong, A. J., George, D. J., Paller, C. J., Apollo, A., … Scher, H. I. (2021). Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. European Urology Open Science, 34, 70–78. https://doi.org/10.1016/j.euros.2021.09.015

Wu, X., Cheng, Y.-S. L., Matthen, M., Yoon, A., Schwartz, G. K., Bala, S., Taylor, A. M., & Momen-Heravi, F. (2021). Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. Journal of Experimental & Clinical Cancer Research, 40(1). https://doi.org/10.1186/s13046-021-01865-2

Grapotte, M., Saraswat, M., Bessière, C., Menichelli, C., Ramilowski, J. A., Severin, J., Hayashizaki, Y., Itoh, M., Tagami, M., Murata, M., Kojima-Ishiyama, M., Noma, S., Noguchi, S., Kasukawa, T., Hasegawa, A., Suzuki, H., Nishiyori-Sueki, H., Frith, M. C., … Lecellier, C.-H. (2021). Discovery of widespread transcription initiation at microsatellites predictable by sequence-based deep neural network. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-23143-7

Melamed, A., Rauh-Hain, J. A., Gockley, A. A., Nitecki, R., Ramirez, P. T., Hershman, D. L., Keating, N., & Wright, J. D. (2021). Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. JAMA Oncology, 7(12), 1782. https://doi.org/10.1001/jamaoncol.2021.4252

Sheikh, T. N., Chen, X., Xu, X., McGuire, J. T., Ingham, M., Lu, C., & Schwartz, G. K. (2021). Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors. Molecular Cancer Therapeutics, 20(12), 2362–2371. https://doi.org/10.1158/1535-7163.mct-21-0066

Sharma, M. R., Carvajal, R. D., Hanna, G. J., Kang, Y. K., Lee, J., Lee, K. W., Li, B. T., Moore, K. N., Pegram, M., Rasco, D., Spira, A., Wang, D., Weinberg, B. A., Alonso, M., Fang, L., Husain, A., Kowanetz, M., Perez, E. A., & Dumbrava, E. I. (2021). 164P Preliminary results from a phase I/II study of BDC-1001, a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), in patients (pts) with advanced HER2-expressing solid tumors. Annals of Oncology, 32, S1453–S1454. https://doi.org/10.1016/j.annonc.2021.10.183

Takeuchi, K., Ariyoshi, Y., Shimizu, A., Okumura, Y., Cara‐Fuentes, G., Garcia, G. E., Pomposelli, T., Watanabe, H., Boyd, L., Ekanayake‐Alper, D. K., Amarnath, D., Sykes, M., Sachs, D. H., Johnson, R. J., & Yamada, K. (2021). Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig‐to‐baboon xenotransplantation. Xenotransplantation, 28(6). Portico. https://doi.org/10.1111/xen.12708